EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

In silico testing to identify compounds that inhibit ClfA and ClfB binding to the host for the formulation of future drugs against Staphylococcus aureus colonization and infection

Shila Kumari Singh, Minakshi Bhattacharjee, Balagopalan Unni, Rajpal Singh Kashyap, Abdul Malik, Suhail Akhtar, Sabiha Fatima

Frontiers in Cellular and Infection Microbiology · 2024

DOI: 10.3389/fcimb.2024.1422500 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2024. Verfasst von Shila Kumari Singh und 6 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Sciences, Assam Downtown University, Guwahati, Assam, India. Hauptthemen laut MEDLINE: Staphylococcus aureus, Molecular Docking Simulation, Molecular Dynamics Simulation, Anti-Bacterial Agents. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: King Saud University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Staphylococcus aureus is a highly resistant pathogen. It has multiple virulence factors, which makes it one of the most pathogenic bacteria for humankind. The vast increase in antibiotic resistance in these bacteria is a warning of existing healthcare policies. Most of the available antibiotics are ineffective due to resistance; this situation requires the development of drugs that target specific proteins and are not susceptible to resistance.

Methods

In this study, we identified a compound that acts as an antagonist of ClfA and ClfB by inhibiting their binding to host cells.

Results

The shortlisted compound’s binding activity was tested by docking and molecular dynamics during its interaction with proteins. The identified compound has excellent binding energy with both ClfA (-10.11 kcal/mol) and ClfB (-11.11 kcal/mol).

Discussion

The molecular dynamics of the protein and compound were stable and promising for further in vitro and in vivo tests. The performance of our compound was tested and compared with that of the control molecule allantodapsone, which was reported in a previous study as a pan inhibitor of the clumping factor. An ADMET study of our selected compound revealed its reliable drug likeliness. This compound is an ideal candidate for in vitro studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Staphylococcus aureusMolecular Docking SimulationMolecular Dynamics SimulationAnti-Bacterial AgentsStaphylococcal InfectionsCoagulaseProtein BindingHumansVirulence FactorsAdhesins, BacterialComputer SimulationDrug Discovery

Stichwörter der Autor:innen

Staphylococcus aureusadhesin binding proteinantimicrobial resistance (AMR)clumping factorcolonizationmolecular docking & molecular dynamics (MD) simulation

Substanzen

Anti-Bacterial AgentsCoagulaseClfA protein, Staphylococcus aureusclfB protein, Staphylococcus aureusVirulence FactorsAdhesins, Bacterial

Autor:innen und Institutionen

  • Faculty of Sciences, Assam Downtown University, Guwahati, Assam, India.
  • Department of Research, Central India Institute of Medical Science, Nagpur, Maharasthra, India.
  • College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.
  • Department of Biochemistry, Andrew Taylor Still University of Health Science, Kirksville, MO, United States.
  • College of Applied Medical Sciences, King Saud University, Riyadh, Saudi Arabia.

Förderung

  • King Saud University

Zitieren

APA

Singh, S. K., Bhattacharjee, M., Unni, B., Kashyap, R. S., Malik, A., Akhtar, S., & Fatima, S. (2024). In silico testing to identify compounds that inhibit ClfA and ClfB binding to the host for the formulation of future drugs against Staphylococcus aureus colonization and infection. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2024.1422500

Vancouver

Singh SK, Bhattacharjee M, Unni B, Kashyap RS, Malik A, Akhtar S, et al. In silico testing to identify compounds that inhibit ClfA and ClfB binding to the host for the formulation of future drugs against Staphylococcus aureus colonization and infection. Frontiers in Cellular and Infection Microbiology. 2024. doi:10.3389/fcimb.2024.1422500

BibTeX
@article{Singh2024,
  author = {Singh, Shila Kumari and Bhattacharjee, Minakshi and Unni, Balagopalan and Kashyap, Rajpal Singh and Malik, Abdul and Akhtar, Suhail and Fatima, Sabiha},
  title = {In silico testing to identify compounds that inhibit ClfA and ClfB binding to the host for the formulation of future drugs against Staphylococcus aureus colonization and infection},
  journal = {Frontiers in Cellular and Infection Microbiology},
  year = {2024},
  doi = {10.3389/fcimb.2024.1422500}
}
Kostenlos starten →